SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-009545
Filing Date
2022-02-28
Accepted
2022-02-28 06:00:57
Documents
12
Period of Report
2022-02-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156243-8k_pluristem.htm   iXBRL 8-K 28667
  Complete submission text file 0001213900-22-009545.txt   203223

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE psti-20220224.xsd EX-101.SCH 3036
3 XBRL LABEL FILE psti-20220224_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE psti-20220224_pre.xml EX-101.PRE 22597
6 EXTRACTED XBRL INSTANCE DOCUMENT ea156243-8k_pluristem_htm.xml XML 3618
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 22683736
SIC: 2836 Biological Products, (No Diagnostic Substances)